Advertisement

Topics

RiverVest Venture Partners Company Profile

20:39 EDT 26th March 2019 | BioPortfolio

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit.


News Articles [487 Associated News Articles listed on BioPortfolio]

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

RiverVest Venture Partners, a St. Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing...

Series B brings in $17mm for Cardialen

Cardialen Inc. (developing a low-energy implantable defibrillation therapy to gently restore normal heart rhythm) raised $17mm in its Series B financing led by RiverVest Venture Partners, which was jo...

RiverVest Venture Partners Closes on Oversubscribed $184.4 Million Life Sciences Fund

Life sciences venture capital firm RiverVest Venture Partners today announced the final closing of RiverVest Venture Fund IV, L.P., reaching $184.4 million in capital commitments ...

Mirum Pharmaceuticals brings in $120mm through Series A round

Mirum Pharmaceuticals (developing treatments for pediatric cholestatic liver diseases) raised $120mm through its Series A round. New Enterprise Associates led and was joined by Deerfield Management, F...

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies

Houston—OncoResponse, a Seattle biotech startup formed jointly with the University of Texas M.D. Anderson Cancer Center in Houston, announced Tuesday it has raised a $40 million Series B round o...

Immunotherapy firm OncoResponse secures $40m series B financing

Participants in the round, which was led by RiverVest Venture Partners, included new investors Qatar Investment Authority (QIA) and Redmile Group, and existing investors Alexandria Venture Investments...

RiverVest closes fourth life science venture fund

Drugs and Medications [66 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [respiratory care partners, inc]

Oxygen

Moderiba [abbvie inc.]

These highlights do not include all the information needed to use Moderiba (ribavirin, USP) safely and effectively. See full prescribing information for Moderiba (ribavirin, USP). Moderiba (ribavirin,...

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Ribavirin [aurobindo pharma limited]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral use Init...

PubMed Articles [260 Associated PubMed Articles listed on BioPortfolio]

Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.

In Kenya, HIV testing during first ANC visit is standard practice for pregnant women. Despite a policy promoting male partner testing in ANC, few male partners accompany their partners for HIV testing...

Trust, Money, and Power: Life Cycle Dynamics in Alliances Between Management Partners and Accountable Care Organizations.

Policy Points Accountable care organizations (ACOs) form alliances with management partners to access financial, technical, and managerial support. Alliances between ACOs and management partners are s...

Targeted HIV testing for male partners of HIV-positive pregnant women in a high prevalence setting in Nigeria.

Partner HIV testing during pregnancy has remained abysmally low in sub-Saharan Africa, particularly in Nigeria. Males rarely attend antenatal clinics with their female partners, limiting the few oppor...

An Innovative Approach to Assess Similarity Between Sex Partners.

We present a simple, comprehensive method for assessing similarity between sex partners of a participant and demonstrate its application using data collected in 2015 as part of CDC's National HIV beha...

A Misguided Venture: Presidential Fitness and the Duty to Warn.

Clinical Trials [359 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [1682 Associated Companies listed on BioPortfolio]

RiverVest Venture Partners

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early-stage life science companies throughout the U.S. to create significant shareholder va...

RiverVest Venture Management, LLC

RiverVest Venture Partners is a venture capital firm investing nationwide in emerging medical device, biopharmaceutical and other healthcare venture opportunities. With a total of more than 80 years o...

Arch Oncology, Inc.

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of p...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

Direct Flow Medical, Inc.

Founded in 2004, the Company is headquartered in Santa Rosa, California, has a second manufacturing facility in Lake Forest, CA and employs 75 people. The Company’s unique im...

More Information about "RiverVest Venture Partners" on BioPortfolio

We have published hundreds of RiverVest Venture Partners news stories on BioPortfolio along with dozens of RiverVest Venture Partners Clinical Trials and PubMed Articles about RiverVest Venture Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RiverVest Venture Partners Companies in our database. You can also find out about relevant RiverVest Venture Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record